Abstract:Editor'China is facing a blood shortage.1Jin YH Cui J Solution for the problem of blood short supply from the perspective of surgical appropriate transfusion.Chin J Blood Transfusion. 2011; 24 ([Chinese]): 451-453Google Scholar Approximately 60% of blood products are being transfused during clinical surgery.2Gong BL Zhang W Meng QL et al.A survey of blood supply in 357 provincial and municipal blood banks.Chin J Blood Transfusion. 2012; 25 ([Chinese]): 1248-1250Google Scholar We aimed to assess the appropriateness of perioperative red blood cells (RBCs) transfusion in public tertiary general hospitals in China. This study was designed as a retrospective (January 2006–December 2009) multicentre survey involving three typical sample hospitals [The Peking Union Medical College Hospital (PUMC Hospital), the Second Affiliated Hospital of Zhejiang University School of Medicine (SAZU Hospital), and the Northern Jiangsu People's Hospital (NJP Hospital)]. Using a year-stratified random sampling with a sampling proportion of 20% for every stratum, 6384 patients who had a history of RBCs transfusion were selected from three hospitals. Of them, 1274 patients, who had complete records of objective indication, were included in the appropriateness evaluation. A structural survey form was used to extract data from the medical records, which included the patients' general information, surgical information, objective transfusion indication, and blood infusion information. The appropriateness evaluation consisted of two steps. First, a reasonableness evaluation was done by a composite criterion that was mainly based on Chinese blood transfusion guidance.3National Health and Family Planning Commission of China Technological Specification for Clinical Use of Blood.Available from http://www.moh.gov.cn/mohyzs/s3589/200804/18676.shtmlGoogle Scholar, 4Emmanuel JC The Clinical Use of Blood. World Health Organization, Malta2001: 255-278Google Scholar, 5Carson JL Grossman BJ Kleinman S Red blood cell transfusion: a clinical practice guideline from the AABB.Ann Intern Med. 2012; 157: 49-58Crossref PubMed Scopus (816) Google Scholar, 6British Committee for Standards in Haematology (BCSH) Guideline on the administration of blood components.Available from http://www.bcshguidelines.com/documents/BCSH_Blood_Admin_-_addendum_August_2012.pdfGoogle Scholar Then, over-transfusion7NHS Blood and Transplant Comparative audit of red cell use in the hospitals in the South West and West Midlands regions.Available from http://hospital.blood.co.uk/library/pdf/Audit_of_Red_cell_Use_in%202_regions_St_Elsewhere's_Hospital.pdfGoogle Scholar was further assessed among patients who were identified as reasonable transfusion based on the first step. During the study periods, the whole blood transfusion was almost replaced by blood component transfusion after the year 2007. The proportion of blood component transfusion increased from 92.3% in 2006 to 99.6% in 2009. Overall, the unreasonable RBCs transfusion rate significantly decreased from 41.5% [95% confidence interval (CI): 35.2–47.9] to 30.2% (25.9–34.7) during the study periods. The downtrends were consistent in all subgroups (38.7–28.8%, 45.2–23.5%, and 41.9–38.9% at the PUMC, the SAZU, and the NJP Hospital, respectively, all P<0.05). Table 1 shows the distribution characteristics of patients who have undergone unreasonable RBCs transfusions. The unreasonable rate in thoracic surgery patients was highest [56.8% (46.3–67.0)], followed by heart/blood vessel surgery patients [47.7% (39.7–55.9)]. Patients without anaemia on admission had more than twice the unreasonable rate as did anaemia patients, especially at the SAZU (64.7% vs 17.9%, P<0.0001) and the NJP Hospital (68.7% vs 24.2%, P<0.0001). In fact, when surgical acute blood loss was replaced by crystalloid or colloid fluids to maintain normovolaemia, in most stable hospitalized patients with adequate preoperative haemoglobin, the loss could often be well tolerated due to normal compensatory responses that are invoked before a blood transfusion becomes necessary.4Emmanuel JC The Clinical Use of Blood. World Health Organization, Malta2001: 255-278Google Scholar, 5Carson JL Grossman BJ Kleinman S Red blood cell transfusion: a clinical practice guideline from the AABB.Ann Intern Med. 2012; 157: 49-58Crossref PubMed Scopus (816) Google ScholarTable 1Distribution characteristics of patients who were identified as unreasonable RBCs transfusions. *95% CIPUMC HospitalSAZU HospitalNJP HospitalTotalUnreasonable transfusion/all patientsUnreasonable rate (95% CI)Unreasonable transfusion/all patientsUnreasonable rate (95% CI)Unreasonable transfusion/all patientsUnreasonable rate (95% CI)Unreasonable transfusion/all patientsUnreasonable rate (95% CI)Gender Male108/25542.4 (36.2–48.7)59/14540.7 (32.6–49.2)76/16047.5 (39.6–55.5)243/56043.4 (39.2–47.6) Female100/34628.9 (24.2–34.0)39/13129.8 (22.1–38.4)65/14744.2 (36.0–52.6)204/62432.7 (29.0–36.5)Anaemia on admission Non-anaemia146/30248.3 (42.6–54.1)66/10264.7 (54.6–73.9)103/15068.7 (60.6–76.0)315/55456.9 (52.6–61.0) Anaemia63/28921.8 (17.2–27.0)31/17317.9 (12.5–24.5)37/15324.2 (17.6–31.8)131/61521.3 (18.1–24.8)Operative sites Head/neck17/3351.5 (33.5–69.2)7/3023.3 (9.9–43.4)14/2458.3 (36.6–77.9)38/8743.7 (33.1–54.7) Thoracic14/3540.0 (23.8–57.9)5/1145.5 (16.8–76.6)35/4971.4 (56.7–83.4)54/9556.8 (46.3–67.0) Abdomen91/28132.4 (27.0–38.2)32/9035.6 (25.7–46.4)49/13835.5 (27.6–44.1)172/50933.8 (29.7–38.1) Limbs/spinal column52/15134.4 (26.9–42.6)41/12433.1 (24.9–42.1)17/6426.6 (16.3–39.1)110/33932.4 (27.5–37.7) Heart/blood vessel35/10234.3 (25.2–44.4)13/2161.9 (38.4–81.9)26/3281.3 (63.6–92.8)74/15547.7 (39.7–55.9) Open table in a new tab Overall, the over-transfusion rate was 10.1%. Nearly, half of the over-transfusion episodes occurred in abdominal operations (consistently in three hospitals). Abdominal surgery accounted for the highest proportion of all surgeries (37.6%) and consumed the largest number of RBCs transfusions (38.4%). Improved transfusion practices during abdomen surgery might conserve scarce blood resources largely because of its substantial operation quantity. After controlling for the hospital, the over-transfusion rate in patients without anaemia on admission was significantly higher than that in anaemic patients (16.9% vs 6.8%, P<0.0001). This study suggests that perioperative blood transfusion is gradually being standardized in China. However, rational blood usage still requires improvements. The low proportion of patients who have complete indication records indicated that an objective indication-guided blood transfusion needs to be further strengthened. Patients who had undergone thoracic, abdominal surgery, or without anaemia on admission were considered as potential populations for blood conservation. Our results are unlikely to be conclusive because of the typical sampling design. Nevertheless, these data have sounded alarm bells for perioperative blood conservation in China. None declared. National Health and Family Planning Commission of the People's Republic of China.

Use of half red blood cell units in oncology patients during severe shortages to extend hospital supply

The Characteristics of Blood Transfusion and Analysis of Preoperative Factors Associated with Intraoperative Blood Transfusion in Congenital Heart Surgery: a Case–control Study

Factors Associated with Red Blood Cell Transfusion among Hospitalized Patients: a Cross-Sectional Study.

Impact of the COVID‐19 outbreak on blood supply in two large university hospitals

Use of Donor-Specific Red Blood Cell Transfusions for Patients Undergoing Liver Transplantation During the COVID-19 Pandemic

Prognostic Impact of Ultra-Restrictive RBC Transfusion in Extensive Burn Patients: a Retrospective Multicenter Cohort Study Running Headline: Ultra-Restrictive Transfusion in Burns

The Impact of COVID-19 on the Blood Supply Chain: Effective Strategies to Avoid Blood Shortage.

Huaxi integrated blood management reduces the red blood cell transfusion for on-pump cardiac surgery: A quasi-experimental study

Whole Blood Program: Implementation in a Rural Trauma Center

Single-Unit Transfusion Is Non Inferior to Double Unit Transfusion in Patients with Hematological Disorders Receiving Allogeneic or Autologous Bone Marrow Transplant or Induction Chemotherapy for Acute Leukemia: The 1versus2 Prospective Multicentric Randomized Clinical Trial

Multicentre Evaluation of Perioperative Red Blood Cells Transfusions in China

Transfusion in Anemic Patients with Acute Coronary Syndromes: A Population-Based Cohort Study

Single-Unit Transfusion Policy in Autologous Hematopoietic Stem Cell Transplantation: Less is Not Worse

Don't Break the (Blood) Bank: Can Waste Be Minimized in a Whole Blood Program?

Improvements in Blood Transfusion Management: Cross-Sectional Data Analysis from Nine Hospitals in Zhejiang, China

Making every drop count: reducing wastage of a novel blood component for transfusion of trauma patients

RhD-positive red blood cell allocation practice to RhD-negative patients before and during the COVID-19 pandemic

Impact of the COVID-19 Pandemic on Blood Transfusion among Hospitalized Patients with Chronic Kidney Disease

A novel measure to summarize blood transfusion practice during critical illness

Reducing Unnecessary Transfusions of RBCs in Inpatients Admitted Across Niagara Health Community Hospitals

Transfusion safety concerns during the COVID-19 pandemic in Taiwan: Altered by evolving control strategies